Dawn Christine Maroney Sells 113,319 Shares of Alignment Healthcare (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 113,319 shares of the firm’s stock in a transaction that occurred on Monday, December 15th. The shares were sold at an average price of $20.01, for a total value of $2,267,513.19. Following the completion of the transaction, the president owned 1,667,237 shares in the company, valued at approximately $33,361,412.37. This trade represents a 6.36% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Dawn Christine Maroney also recently made the following trade(s):

• On Friday, December 12th, Dawn Christine Maroney sold 16,681 shares of Alignment Healthcare stock. The stock was sold at an average price of $20.02, for a total value of $333,953.62.

Alignment Healthcare Stock Up 3.9%

ALHC traded up $0.75 on Monday, reaching $20.11. The company’s stock had a trading volume of 3,366,998 shares, compared to its average volume of 3,039,179. The business’s 50 day moving average is $17.65 and its 200 day moving average is $15.84. The stock has a market cap of $4.02 billion, a price-to-earnings ratio of -167.58 and a beta of 1.16. The company has a debt-to-equity ratio of 1.99, a current ratio of 1.61 and a quick ratio of 1.61. Alignment Healthcare, Inc. has a 1 year low of $10.18 and a 1 year high of $21.06.

Alignment Healthcare (NASDAQ:ALHC) last issued its earnings results on Thursday, October 30th. The company reported $0.02 EPS for the quarter, topping the consensus estimate of ($0.01) by $0.03. The firm had revenue of $993.70 million during the quarter, compared to analysts’ expectations of $980.90 million. Alignment Healthcare had a negative return on equity of 16.23% and a negative net margin of 0.57%.Alignment Healthcare’s quarterly revenue was up 43.5% compared to the same quarter last year. During the same period last year, the business earned ($0.14) earnings per share. As a group, research analysts forecast that Alignment Healthcare, Inc. will post -0.69 EPS for the current fiscal year.

Institutional Investors Weigh In On Alignment Healthcare

Several hedge funds and other institutional investors have recently bought and sold shares of ALHC. Larson Financial Group LLC bought a new position in Alignment Healthcare in the third quarter valued at about $33,000. SBI Securities Co. Ltd. raised its stake in shares of Alignment Healthcare by 4,868.9% during the second quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company’s stock worth $42,000 after acquiring an additional 2,970 shares in the last quarter. KBC Group NV bought a new position in Alignment Healthcare during the 2nd quarter valued at about $44,000. Signaturefd LLC lifted its stake in shares of Alignment Healthcare by 142.6% in the 2nd quarter. Signaturefd LLC now owns 3,768 shares of the company’s stock valued at $53,000 after purchasing an additional 2,215 shares during the last quarter. Finally, Wilmington Savings Fund Society FSB acquired a new position in shares of Alignment Healthcare in the 3rd quarter valued at $53,000. 86.19% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several analysts have recently issued reports on ALHC shares. The Goldman Sachs Group reiterated a “buy” rating and issued a $22.00 price objective on shares of Alignment Healthcare in a research note on Monday, November 3rd. Weiss Ratings restated a “sell (d-)” rating on shares of Alignment Healthcare in a research report on Wednesday, October 8th. UBS Group upped their price target on shares of Alignment Healthcare from $17.00 to $18.00 and gave the stock a “neutral” rating in a report on Friday, October 31st. KeyCorp reiterated an “overweight” rating on shares of Alignment Healthcare in a report on Monday, November 24th. Finally, Wall Street Zen raised Alignment Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, November 8th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $20.05.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.